On October 28, local time, U.S. stocks fell sharply on Wednesday due to concerns about the growth of new coronavirus infections and its potential impact on the global economy. The Dow Jones Industrial Average fell about 943.24 points to close at 26,519.95 points, a drop of 3.43%, marking its worst day since June 11. The S&P 500 fell 3.53% and the Nasdaq Composite fell 3.73%.
The Dow Jones has fallen so far this week 6.4%, the largest weekly drop since March. The S&P 500 fell 5.6% during the period and had its worst week since March. The tech-heavy Nasdaq fell 4.7% this week.
The plunge in overseas markets is inseparable from the rebound of overseas epidemics.
New cases in many European and American countries have broken records again
In the United States, on October 28, local time, according to Johns. According to real-time data from Hopkins University, as of 5:24 pm Eastern Time on the 28th, the number of confirmed cases of COVID-19 in the United States reached 8,836,861, and the number of deaths related to COVID-19 reached 227,409. The data increased by 69,877 cases and 885 cases respectively from 24 hours ago.
In Europe, according to statistics from the British Department of Health and Social Security, as of 16:00 local time on October 28, there were 24,701 new confirmed cases of COVID-19 in the UK within 24 hours, with a total of 942,275 confirmed cases. cases; there were 310 new deaths, a total of 45,675 deaths within 28 days after diagnosis, and a total of 59,235 deaths.
On the 28th local time, the latest statistics released by the Italian Ministry of Health showed that the total number of confirmed cases of new coronary pneumonia in Italy was 589,766, and 24,991 new cases were added within 24 hours. , the highest number of new cases in a single day since the outbreak, and the third time this month that the number of new cases exceeded 20,000 per day. In addition, there were 205 new deaths on the 28th, bringing the total number of deaths to 37,905. There are currently 276,457 confirmed cases, including 1,536 severe cases.
Many countries have adopted blockade measures again
On the evening of the 28th local time, French President Macron announced that France would start from October 30 The lockdown measures will be re-implemented and will last until at least December 1 to cope with the rapid rebound of the new coronavirus pneumonia epidemic.
At the same time, German Chancellor Merkel held a “New Crown Summit” with the governors of various federal states to formulate unified national epidemic prevention and control measures. It is understood that Germany will implement a stricter social contact ban than the current measures from November 2, and the tentative implementation period will be throughout November.
On the afternoon of the 28th, the Swiss Confederation held a press conference to announce the latest epidemic prevention measures. Starting from the 29th, the new epidemic prevention measures will be implemented without an end date. All nighttime entertainment venues will be closed throughout Switzerland; restaurants and bars can have a maximum of 4 people per table; all restaurants and bars will be closed from 11pm every night to 6pm the next day. All large-scale activities with more than 50 people, especially cultural and sports activities, are prohibited; all non-professional sports and cultural activities with more than 15 people are prohibited.
The vaccine that carries all hope is “still half-hidden”
Recently, according to news from Brazil’s “Globe”, A volunteer participating in the Oxford University COVID-19 vaccine trial died. The deceased volunteer was a 28-year-old male doctor who had worked at a hospital in Rio since March this year. It is reported that the volunteer was in good health before and received the vaccine jointly developed by Oxford University and AstraZeneca in late July. However, he was still infected with the new coronavirus in September this year and unfortunately died of new coronavirus pneumonia and complications on the 15th of this month. Brazil’s National Health Supervision Agency said that the agency was officially informed of this information on the 19th, and the authenticity of the information has been confirmed. Regarding the death of the above-mentioned volunteer, relevant institutions such as Oxford University and AstraZeneca have stated that due to confidentiality agreements, relevant information cannot be disclosed to the outside world. This is not the first time a problem has arisen with the COVID-19 vaccine. In October this year, 45-year-old Spaniard Joan Pons Laplana was diagnosed positive. In June, he voluntarily accepted a human trial test of the COVID-19 vaccine developed by the University of Oxford in the United Kingdom.
▲The chimpanzee holds a syringe and wears an experimental coat from the vaccine manufacturer AstraZeneca
On the evening of September 8, AstraZeneca The COVID-19 vaccine, which was in its third phase of clinical trials, was halted due to “severe side effects” in a subject. At present, AstraZeneca Pharmaceuticals and Oxford University have restarted clinical trials related to the new crown vaccine.
In addition, Johnson & Johnson’s new crown vaccine also encountered problems. On October 12, the US company Johnson & Johnson announced that due to an “unexplained illness” in a subject, the company decided to suspend the clinical trial of a new coronavirus vaccine candidate developed by its Janssen Pharmaceutical Company. Johnson & Johnson issued a statement that day stating that the company would suspend all clinical trials of the vaccine, including the Phase III clinical trial launched at the end of September.
Will the global economy, which has just improved, return to before liberation?
According to the latest statistics from the U.S. Bureau of Statistics, U.S. retail sales of goods increased by 1.9% month-on-month in September, the largest increase in the past three months, with a year-on-year increase of 1.9%.5.4%. Among them, the retail sales of clothing and apparel increased by 11% month-on-month and decreased by 12.5% year-on-year, returning to nearly 90% before the epidemic. The U.S. apparel market has maintained a recovery trend for five consecutive months. After the rebound momentum slowed down in August, the recovery momentum of clothing retail sales became rapid in September.
According to retail statistics released by the British Bureau of Statistics, British retail sales in September increased by 1.5% compared with August. This is the fifth consecutive month of growth. Compared with February before the outbreak, sales increased by 5.5%. UK fuel sales in September were 2.8% lower than February, clothing sales were 12.7% lower, and sales of home furnishings and gardening supplies performed well, each exceeding February retail sales by more than 10%.
Domestic consumption in the United Kingdom and the United States has maintained growth for five consecutive months, bringing a glimmer of light to the bleak global economy. Coinciding with the end of the year holiday consumption season, domestic textile Corporate orders have also gradually improved, and the situation from raw materials to products has surged. However, the resurgence of the COVID-19 epidemic has dealt another blow to the industry’s recovery. Textile workers can no longer bear the tragedy of being cut off.
Since the National Day holiday, news of the return of overseas orders has been rampant, which has led to a crazy counterattack in the entire textile market. After the dust has settled and we return to fundamentals, we will find that domestic “Double 11” orders have been delivered, orders from India are better than nothing, Christmas and New Year orders are now uncertain, prices of cotton, staple fiber and other raw materials have fallen from highs, and gauze prices Expectations for improving downstream demand are still high. The epidemic is back again. Can the orders you have in hand still support the prices of the products that are waiting for you?
</p